[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX12896A - Procedimiento para preparar un compuesto de espiro-heteroazolonas - Google Patents

Procedimiento para preparar un compuesto de espiro-heteroazolonas

Info

Publication number
MX12896A
MX12896A MX1289688A MX1289688A MX12896A MX 12896 A MX12896 A MX 12896A MX 1289688 A MX1289688 A MX 1289688A MX 1289688 A MX1289688 A MX 1289688A MX 12896 A MX12896 A MX 12896A
Authority
MX
Mexico
Prior art keywords
heteroazolon
spyro
preparing
procedure
compound
Prior art date
Application number
MX1289688A
Other languages
English (en)
Inventor
Steven Wayne Goldstein
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX12896A publication Critical patent/MX12896A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX1289688A 1987-09-04 1987-09-04 Procedimiento para preparar un compuesto de espiro-heteroazolonas MX12896A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/002196 WO1989001775A1 (en) 1987-09-04 1987-09-04 Azolidinedione derivatives

Publications (1)

Publication Number Publication Date
MX12896A true MX12896A (es) 1993-06-01

Family

ID=22202540

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1289688A MX12896A (es) 1987-09-04 1987-09-04 Procedimiento para preparar un compuesto de espiro-heteroazolonas

Country Status (21)

Country Link
EP (1) EP0306251A3 (es)
JP (1) JPS6471882A (es)
KR (1) KR900008841B1 (es)
CN (1) CN1022325C (es)
AU (1) AU595467B2 (es)
CS (1) CS273186B2 (es)
DD (1) DD273381A5 (es)
DK (1) DK488688A (es)
EG (1) EG18591A (es)
FI (1) FI901087A0 (es)
HU (1) HU204832B (es)
IL (1) IL87590A (es)
MX (1) MX12896A (es)
MY (1) MY103765A (es)
NO (1) NO901016L (es)
PH (1) PH24957A (es)
PL (1) PL156798B1 (es)
PT (1) PT88407B (es)
WO (1) WO1989001775A1 (es)
YU (1) YU46863B (es)
ZA (1) ZA886507B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
KR101308227B1 (ko) * 2005-04-21 2013-09-13 이시하라 산교 가부시끼가이샤 니코틴산 유도체 또는 그의 염의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
DE3262294D1 (en) * 1981-05-13 1985-03-28 Ici Plc Pharmaceutical compositions containing spiro succinimide derivatives

Also Published As

Publication number Publication date
CS273186B2 (en) 1991-03-12
HU204832B (en) 1992-02-28
MY103765A (en) 1993-09-30
JPS6471882A (en) 1989-03-16
FI901087A0 (fi) 1990-03-02
IL87590A (en) 1992-07-15
DK488688A (da) 1989-04-07
CN1022325C (zh) 1993-10-06
PL156798B1 (pl) 1992-04-30
PH24957A (en) 1990-12-26
DD273381A5 (de) 1989-11-15
EP0306251A3 (en) 1990-08-01
EP0306251A2 (en) 1989-03-08
KR890005112A (ko) 1989-05-11
KR900008841B1 (ko) 1990-11-30
NO901016L (no) 1990-05-02
CS591188A2 (en) 1990-06-13
PL274504A1 (en) 1989-05-02
AU595467B2 (en) 1990-03-29
AU2184188A (en) 1989-03-09
EG18591A (en) 1993-06-30
HUT56106A (en) 1991-07-29
YU167788A (en) 1990-06-30
JPH0583554B2 (es) 1993-11-26
PT88407A (pt) 1989-07-31
DK488688D0 (da) 1988-09-02
IL87590A0 (en) 1989-01-31
PT88407B (pt) 1992-10-30
NO901016D0 (no) 1990-03-02
ZA886507B (en) 1990-04-25
WO1989001775A1 (en) 1989-03-09
YU46863B (sh) 1994-06-24
CN1031702A (zh) 1989-03-15

Similar Documents

Publication Publication Date Title
ES548135A0 (es) Un procedimiento para preparar dioxafosforinanos
ES542051A0 (es) Un procedimiento para preparar derivados de benzoilurea
ES543047A0 (es) Un procedimiento para preparar un derivado de pirimidina
ES551514A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES545347A0 (es) Un procedimiento para preparar derivados de pirimidina
MX164160B (es) Un procedimiento para preparar un compuesto neoalcoxi
ES552089A0 (es) Un procedimiento para preparar compuestos de oxazolidina-fenol-alcohol
ES548409A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES544863A0 (es) Un procedimiento para preparar un compuesto de beta-lactama
ES547419A0 (es) Un procedimiento para preparar derivados de pirimidina
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES545111A0 (es) Un procedimiento para preparar un derivado de fluoralilamina
ES545894A0 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES546690A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indoldiona
ES552138A0 (es) Un procedimiento para preparar poliarilen-polieteres
ES550525A0 (es) Un procedimiento para preparar un derivado de piridinilmeti-cetona
ES547458A0 (es) Un procedimiento para preparar derivados de piridiloxi
ES544381A0 (es) Un procedimiento para preparar 5-desoxi-l-arabinosa
ES545130A0 (es) Un procedimiento para preparar un compuesto de piridoben- zodiazepina
ES541321A0 (es) Procedimiento para preparar un derivado de fenotiazina
ES546669A0 (es) Un procedimiento para preparar compuestos relacionados con histargina
ES557574A0 (es) Un procedimiento para preparar nuevos compuestos de 2-oxa-o -aza-pregnano